HADH gene
The HADH gene encodes an enzyme vital for breaking down medium- and short-chain fatty acids to provide energy for the heart, muscles, and other tissues.
Overview
The HADH gene provides instructions for making the enzyme 3-hydroxyacyl-CoA dehydrogenase. This enzyme is a key player in fatty acid oxidation, the process of breaking down fats to generate energy. It specifically targets medium-chain and short-chain fatty acids, which are found in dietary fats or produced when larger fatty acids are metabolized.
Functioning within the mitochondria, this enzyme is essential for the health of the heart, liver, kidneys, muscles, and pancreas. It helps convert fatty acids into ketones, which serve as a primary energy source for the heart and muscles, especially during fasting or periods of high energy demand.
Health Conditions Related to Genetic Changes
3-hydroxyacyl-CoA dehydrogenase deficiency
Mutations in the HADH gene can lead to 3-hydroxyacyl-CoA dehydrogenase deficiency. These genetic changes alter the 3-dimensional shape of the enzyme, impairing its function. Consequences include:
- Inability to properly metabolize medium- and short-chain fatty acids.
- Lack of energy (lethargy) and low blood glucose (hypoglycemia).
- Potential damage to the liver, heart, and muscles due to the accumulation of unprocessed fatty acids.
Other disorders
Mutations in the HADH gene have also been identified in individuals with familial hyperinsulinism. This condition is characterized by:
- Abnormally high levels of insulin (hyperinsulinism).
- Unusually low blood glucose (hypoglycemia).
- Reduced enzyme activity in the pancreas, which researchers believe leads to excessive insulin secretion.
